EPI
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Epiminder Limited is a medical device company developing the Minder system, an implantable continuous electroencephalogram (EEG) monitoring device for patients with drug-resistant epilepsy. The Minder iCEM is a minimally invasive sub-scalp monitor approved by the US FDA in April 2025 for continuous brain activity recording over periods of up to three years. The company serves neurologists and epilepsy patients in the United States and Australia, supporting clinical decision-making through objective long-term seizure data. Epiminder was established in 2018 as a research collaboration involving the Bionics Institute, the University of Melbourne, St Vincent's Hospital Melbourne, and Cochlear. The company is currently conducting the DETECT post-approval trial in the US to generate evidence for payer reimbursement and is developing a next-generation Minder implant system.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Health Care Equipment & Services Homepage epiminder.com
Sector Healthcare IR page epiminder.com
Tags
neurology, epilepsy, implantable devices, eeg monitoring, chronic disease management, clinical diagnostics, Minder, Minder iCEM, DETECT, UMPIRE
Press page —

Metrics

Valuation  
Market cap A$ 58.501M
P/E -1.37
P/BV 0.49
P/S —
P/OCF -1.35
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE -52.3%
ROI -52.3%
ROIC -52.3%
Profit margin —
Growth  
Revenue growing —
Profits growing No
Revenue up 3y —
Revenue up 5y —
Quality  
Profitable No
Margin expanding —
Buying back stock Yes
Diluting (TTM) —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -40.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025
Assets 90.838M 22.608M
Net profit -42.733M -31.779M

Figure FY 2026 FY 2025
Share price 0.44 —
P/OCF -1.53 —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Epiminder Limited (ticker EPI), listed in Australia.